Clinical Trial Update: Reliability of Point-of-care INR Measurements in Patients With Antiphospholipid-antibody Syndrome Treated With Warfarin

View source ↗

Summary

This completed trial evaluated the reliability of point-of-care INR measurements in patients with antiphospholipid syndrome treated with warfarin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome

Drugs mentioned

• Coumadin (warfarin)
• Warfarin (warfarin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Antiphospholipid Syndrome | Status: COMPLETED